Introduction of newer vaccines in national immunization programme in India: a challenge

Authors

  • Ramesh Verma Department of Community Medicine, Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences, Rohtak, Haryana, India
  • Vinod Chayal Department of Community Medicine, Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences, Rohtak, Haryana, India
  • Meenakshi Kalhan Department of Community Medicine, Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences, Rohtak, Haryana, India
  • Rohit Dhaka Department of Community Medicine, Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences, Rohtak, Haryana, India
  • Suraj Chawla Department of Community Medicine, SHKM Government Medical College, Nalhar, Haryana, India
  • Kapil Bhalla Department of Pediatric, Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences, Rohtak, Haryana, India

DOI:

https://doi.org/10.18203/2394-6040.ijcmph20202021

Keywords:

Immunization, Newer vaccine, Disease, Epidemic, Surveillance

Abstract

Immunization significantly reduces the incidence of communicable diseases in children and improves the quality of life of children. Many developing countries including India, is lagging behind in sufficient coverage of routine immunization among children. Currently, India manufactures about 43% of the global vaccines. Newer vaccine research can be promoted only when there is conducive environment, funding and subsequent chances of vaccine being introduced in the universal immunization programme (UIP).  Government of India has a National Vaccine Policy which was developed after the recommendations made by National Technical Advisory Group on Immunization.This policy addresses the issues to streamline the process on new and underutilized vaccine and also suggests to strengthen the institutional framework, processes, evidence base and framework required for decision making for strengthening of UIP in India. Government of India laid some standard guidelines and few criteria for the introduction of new vaccine in UIP. While planning to introduce a newer vaccine, cost effectiveness of the vaccination program should be kept in mind.

References

Puliyel J. Vaccine policy and advance market commitments. Econ Pol Wkly. 2011;46(44-45):18-9.

Bhan A. Ethical considerations in developing a national vaccine policy. Indian J Med Res. 2010;132:226-7.

Ahmad F. U.S. Advisory Committee on Immunization Practices (ACIP) Handbook for Developing Evidence-based Recommendations. Version 1.1, National Center for Immunization and Respiratory Diseases Centers for Disease Control and Prevention (CDC) Atlanta, GA, USA; 2012: 1-46.

New initiatives help India achieve improved coverage and quality of immunization. Press Information Bureau, Government of India, Ministry of Health and Family Welfare. Available at: http://pib.nic.in/newsite/erelease.aspx?relid=73623.Accessed on 3 January 2020.

Madhavi Y, Puliyel JM, Mathew LJ, Raghuram N, Phadke A, Shiva M, Srinivasan S. Evidence-based National Vaccine Policy. Indian J Med Res. 2010;131:617-28.

Ministry of Health and Family Welfare. National Vaccine Policy April 2011. MoHFW, Government of India. Nirman Bhawan New Delhi, 2011.

Downloads

Published

2020-04-24

How to Cite

Verma, R., Chayal, V., Kalhan, M., Dhaka, R., Chawla, S., & Bhalla, K. (2020). Introduction of newer vaccines in national immunization programme in India: a challenge. International Journal Of Community Medicine And Public Health, 7(5), 1998–2000. https://doi.org/10.18203/2394-6040.ijcmph20202021

Issue

Section

Editorial